Les Laboratoires SERVIER

Type: Company
Name: Les Laboratoires SERVIER
First reported Oct 17 2014 - Updated Oct 17 2014 - 1 reports

Servier Canada opens Clinical Development Center in Montreal

Servier Canada, the Canadian subsidiary of Servier , has opened its new Clinical Development Center in Montreal.The mission for this new center is participation in the design and development of Servier's international clinical research. It will coordinate ... [Published Center Watch - Oct 17 2014]
First reported Oct 14 2014 - Updated Oct 14 2014 - 3 reports

SERVIER CANADA is opening its new Clinical Development Centre in Montreal, and announces a $750,000 fund at UdeM

LAVAL. QC, Oct. 10, 2014 /CNW Telbec/ - Servier Canada, the Canadian subsidiary of Servier, has today opened its new Clinical Development Centre in Montreal in the presence of Ms. Francine Charbonneau, Minister of Families and Minister responsible for ... [Published PR Newswire: General Business - Oct 14 2014]
First reported Oct 13 2014 - Updated Oct 13 2014 - 1 reports

Servier Canada opens new clinical development center in Montreal

Servier Canada, which is engaged in research in fields of cardiovascular and neuropsychiatric diseases, has opened its new clinical development center in Montreal. Mr Olivier Laureau has been recently appointed head of Groupe Servier, and is also President ... [Published Individual.com - Oct 13 2014]
First reported Oct 10 2014 - Updated Oct 11 2014 - 1 reports

SERVIER CANADA is opening its new Clinical Development Centre in Montreal, and announces a $750 000$ fund at UdeM

LAVAL, QC, Oct. 10, 2014 /CNW Telbec/ - Servier Canada, the Canadian subsidiary of Servier, has today opened its new Clinical Development Centre in Montreal in the presence of Ms. Francine Charbonneau, Minister of Families and Minister responsible for ... [Published Scottrade - Oct 10 2014]
First reported Oct 08 2014 - Updated Oct 08 2014 - 1 reports

Media invitation - Servier Canada's inauguration of its new clinical development centre and Creation of a Research and Teaching Fund

MONTREAL , Oct. 8 2014 /CNW Telbec/ - Media are invited to Servier Canada's inauguration of its new clinical development centre.Announcement of the Creation of a Research and Teaching Fund for the Faculty of Pharmacy of the University of Montreal : The ... [Published Stockboard Media Inc. - Oct 08 2014]
First reported Oct 07 2014 - Updated Oct 07 2014 - 1 reports

Servier Enters R&D Partnership To Find Effective Blood Cancer Treatments

By Lori ClapperFrench pharmaceutical company Servier and the Walter and Eliza Hall Institute , Australia’s oldest medical research organization, have entered into a partnership to develop new agents specifically targeted to treat blood cancers, as well ... [Published Bioresearch Online - Oct 07 2014]
First reported Oct 04 2014 - Updated Oct 04 2014 - 1 reports

Serviers new research partnership with Walter and Eliza Hall Institute

French independent pharma company Servier has established a collaborative partnership with Australia’s Walter and Eliza Hall Institute to facilitate the development of new agents that could be effective in treating several types of cancer, particul.. ... [Published BioPortfolio - Oct 04 2014]
First reported Oct 02 2014 - Updated Oct 02 2014 - 1 reports

Competition Law in the Pharma Sector

The pharmaceutical sector is still facing tough times. Last month the European Commission imposed a fine of 427 million Euros on Servier and several other pharmaceutical companies for breaching EU competition law rules.Keeping up to date and evaluating ... [Published Concurrences - Oct 02 2014]
First reported Oct 02 2014 - Updated Oct 02 2014 - 1 reports

New research partnership with Servier to target Achilles’ heel of many cancers

The European pharmaceutical company Servier has established a collaborative partnership with the Walter and Eliza Hall Institute to facilitate the development of new agents that could be effective in treating several types of cancer, particularly blood ... [Published Health Canal - Oct 02 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 1 reports

Servier abandons cancer drug collaboration with Pharmacyclics

Servier has ended its collaboration on a prospective new cancer treatment and will return abexinostat's global development and commercialisation rights to Pharmacyclics.A pan-HDAC inhibitor, abexinostat is currently in phase II clinical trials for B-cell ... [Published PMLive - Sep 29 2014]
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

BioNews [9.26.14]

Top News HeadlineCompanyType Pharmacyclics and Servier Agree to Conclude Pan-HDAC Inhibitor Collaboration Pharmacyclics & ServierEnded Collaboration This Switch Could Make Gilead Sciences, Inc. Stock Billions Gilead Sciences, Inc.Block ... [Published eClinical Trends - Sep 26 2014]
First reported Sep 25 2014 - Updated Sep 26 2014 - 7 reports

Servier and Pharmacyclics end collaboration on abexinostat pan-HDAC inhibitor compounds

French privately-held drugmaker Servier is to end its collaboration with Pharmacyclics (Nasdaq: PCYC) in the development of the latter’s pan-HDAC inhibitor compounds involving abexinostat outside the USA. The global development and commercialization rights ... [Published Pharma Letter - Sep 26 2014]

Quotes

"ŸWe are today very proud to open the doors to our new centre for excellence in clinical development just over one year after its announcement. This $17M investment illustrates the importance of research to our growth model. We have invested a total of $100M over the past five years in Canada, explained Servier Canada CEO Mr. Frédéric Fasano."
...Ebeling is president of the Endocrine Society of Australia. "In fact, 1 in 5 men over the age of 50 years will sustain a fracture due to osteoporosis in their lifetime." This is in contrast to 1 in 3 women over 50 who will have an osteoporosis-related fracture
"We are today very proud to open the doors to our new centre for excellence in clinical development just over one year after its announcement. This $17M investment illustrates the importance of research to our growth model. We have invested a total of $100M over the past five years in Canada, explained Servier Canada CEO Mr. Frédéric Fasano. Another clear sign of this commitment to medical research in Quebec is the creation of the 'Dr Madeleine Tremblay Servier and Groupe Servier fund for the development of medicinal products' ($750,000) at the Faculty of Pharmacy of the Université de Montréal. This fund is dedicated to the education of future talent in the pharmaceutical industry and named after Dr Madeleine Tremblay Servier, born in Quebec who graduated from UdeM's Faculty of Pharmacy, and internationally renowned for her distinguished career in the pharmaceutical industry. Founder of Servier Canada in 1978 and a pioneer in the international development of the group, Dr. Tremblay Servier now chairs the' Collège International de Recherche Servier"
Ian Garland, CEO of Vernalis commented "We are delighted to establish our base in the US and welcome Pascal to the team. His knowledge and experience perfectly complement our current team's expertise as Vernalis continues to grow its US commercial business in preparation for the expected launch in 2015 of its first cough cold product Tuzistra XR."

More Content

All (122) | News (104) | Reports (0) | Blogs (14) | Audio/Video (0) | Fact Sheets (2) | Press Releases (2)
sort by: Date | Relevance
The Technology Transfer Block Exemption [Published Out-Law.com - 3 hours ago]
Servier Canada opens Clinical Development Cente... [Published Center Watch - Oct 17 2014]
SERVIER CANADA is opening its new Clinical Deve... [Published PR Newswire: General Business - Oct 14 2014]
Pharmplanet became a top-five among pharmaceuti... [Published PharmiWeb - Oct 14 2014]
SERVIER CANADA is opening its new Clinical Deve... [Published BusinessWeek - Oct 14 2014]
SERVIER CANADA is opening its new Clinical Deve... [Published PR Newswire: Health - Oct 14 2014]
Stents [Published Lancet - Oct 14 2014]
Servier Canada opens new clinical development c... [Published Individual.com - Oct 13 2014]
XOMA Starts Phase I Study on XOMA 358 for Hyper... [Published Yahoo! Finance - Oct 10 2014]
The Dangers of Thinning Bones as Men Age [Published KTVU - Oct 10 2014]
SERVIER CANADA is opening its new Clinical Deve... [Published Scottrade - Oct 10 2014]
Giant Cell Arteritis Global Clinical Trials Rev... [Published Digital Journal - Oct 10 2014]
Pharmplanet became a top-five among pharmaceuti... [Published Prlog - Oct 10 2014]
Sales of heart failure drugs set to soar [Published Pharma Times - Oct 10 2014]
Vernalis Opens US Office and Strengthens US Tea... [Published MoneyShow.com - Oct 10 2014]
XOMA Launches XOMA 358 Clinical Development [Published Pettinga Financial Advisors - Oct 09 2014]
The Weaker Sex: Men With Osteoporosis Are Negle... [Published General Medicine eJournal - Oct 09 2014]
Vernalis Licenses V2006 to RedoxTherapies Inc f... [Published Digital Journal - Oct 09 2014]
Media invitation - Servier Canada's inauguratio... [Published Stockboard Media Inc. - Oct 08 2014]
From decisions to disorders: how neuroscience i... [Published Conversation UK - Oct 08 2014]
Servier Enters R&D Partnership To Find Effectiv... [Published Bioresearch Online - Oct 07 2014]
2014 Stable Angina Therapeutics Clinical Trials... [Published MyNewsDesk - Oct 07 2014]
SPRINTT Project: the First European Collaborati... [Published FinanzNachrichten.de - Oct 07 2014]
The Texas A&M University System and XOMA Licens... [Published Wall Street Select - Oct 06 2014]
Focus on regulatory law - October 2014 [Published Lexology - Oct 06 2014]
Managed Access Programmes: maintaining treatmen... [Published pharmaphorum - Oct 06 2014]
Serviers new research partnership with Walter a... [Published BioPortfolio - Oct 04 2014]
Only DM duration independently tied to microvas... [Published Medical Xpress - Oct 03 2014]
Karolinska Development's CEO leaves, Erytech hi... [Published FierceBiotech - Oct 02 2014]
Competition Law in the Pharma Sector [Published Concurrences - Oct 02 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
SERVIER CANADA is opening its new Clinical Deve... [Published PR Newswire: General Business - Oct 14 2014]
LAVAL. QC, Oct. 10, 2014 /CNW Telbec/ - Servier Canada, the Canadian subsidiary of Servier, has today opened its new Clinical Development Centre in Montreal in the presence of Ms. Francine Charbonneau, Minister of Families and Minister responsible for ...
SERVIER CANADA is opening its new Clinical Deve... [Published PR Newswire: Health - Oct 14 2014]
LAVAL. QC, Oct. 10, 2014 /CNW Telbec/ - Servier Canada, the Canadian subsidiary of Servier, has today opened its new Clinical Development Centre in Montreal in the presence of Ms. Francine Charbonneau, Minister of Families and Minister responsible for ...
BioNews [9.26.14] [Published eClinical Trends - Sep 26 2014]
Top News HeadlineCompanyType Pharmacyclics and Servier Agree to Conclude Pan-HDAC Inhibitor Collaboration Pharmacyclics & ServierEnded Collaboration This Switch Could Make Gilead Sciences, Inc. Stock Billions Gilead Sciences, Inc.Block ...
Pharmacyclics and Servier agree to conclude Pan... [Published PBR - News - Sep 26 2014]
Pharmacyclics and Servier announced that they have mutually and amicably ended their collaboration pertaining to the ex-U.S. development of Pharmacyclics' pan-HDAC inhibitor compounds involving abexinostat, thereby returning global development and commercialization ...
Pharmacyclics and Servier Agree to Conclude Pan... [Published PR Newswire: Health - Sep 25 2014]
SUNNYVALE, Calif. and SURESNES, France, Sept. 25, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) and Servier today announced that they have mutually and amicably ended their collaboration pertaining to the ex-U.S. development of Pharmacyclics' ...
1 2 3

Press Releases

sort by: Date | Relevance
Galapagos receives milestone in osteoarthritis ... [Published GlobeNewswire: Advertising News - Aug 05 2014]
MacroGenics' DART Candidate IND for Colorectal ... [Published GlobeNewswire: Acquisitions News - Jul 24 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.